Vontobel Holding’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $586K | Buy |
2,680
+17
| +0.6% | +$3.72K | ﹤0.01% | 746 |
|
2025
Q1 | $596K | Sell |
2,663
-206
| -7% | -$46.1K | ﹤0.01% | 728 |
|
2024
Q4 | $940K | Buy |
2,869
+175
| +6% | +$57.3K | ﹤0.01% | 615 |
|
2024
Q3 | $809K | Buy |
2,694
+316
| +13% | +$94.9K | ﹤0.01% | 646 |
|
2024
Q2 | $783K | Sell |
2,378
-224
| -9% | -$73.8K | ﹤0.01% | 636 |
|
2024
Q1 | $1.03M | Buy |
2,602
+127
| +5% | +$50.3K | 0.01% | 578 |
|
2023
Q4 | $871K | Sell |
2,475
-148
| -6% | -$52.1K | 0.01% | 632 |
|
2023
Q3 | $984K | Sell |
2,623
-350
| -12% | -$131K | 0.01% | 587 |
|
2023
Q2 | $1.14M | Sell |
2,973
-1,474
| -33% | -$564K | 0.01% | 565 |
|
2023
Q1 | $1.54M | Sell |
4,447
-1,658
| -27% | -$574K | 0.01% | 479 |
|
2022
Q4 | $1.41M | Buy |
6,105
+698
| +13% | +$161K | 0.01% | 493 |
|
2022
Q3 | $1.33M | Sell |
5,407
-13
| -0.2% | -$3.2K | 0.02% | 484 |
|
2022
Q2 | $1.62M | Sell |
5,420
-1,155
| -18% | -$346K | 0.02% | 426 |
|
2022
Q1 | $2.75M | Sell |
6,575
-709
| -10% | -$296K | 0.02% | 370 |
|
2021
Q4 | $3.43M | Buy |
7,284
+379
| +5% | +$179K | 0.03% | 331 |
|
2021
Q3 | $2.93M | Sell |
6,905
-674
| -9% | -$286K | 0.03% | 371 |
|
2021
Q2 | $2.73M | Buy |
7,579
+798
| +12% | +$287K | 0.02% | 384 |
|
2021
Q1 | $1.91M | Sell |
6,781
-191
| -3% | -$53.8K | 0.01% | 409 |
|
2020
Q4 | $2.05M | Buy |
+6,972
| New | +$2.05M | 0.01% | 368 |
|